Bryn Jones

5PUBLICATIONS
15CO-AUTHORS
Epidemiological methodsGene and molecular therapyMedical biotechnology diagnostics (incl. biosensors)Epigenetics (incl. genome methylation and epigenomics)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 07, 2026
Similar Efficacy, Safety, and Immune Improvement Through 96 Weeks in Individuals With Limited HIV-1 Treatment Options Using Twice-Daily Dolutegravir- or Fostemsavir-based Regimens.

|Aug 14, 2026
VOGUE: Noninferior Efficacy of Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults With HIV-1 Naive to Treatment.

|Jul 16, 2026
Impact of HIV-1 RNA Assay Selection on Low-Level Viremia and Clinical Trial Endpoint Interpretations.

|Mar 28, 2024
Dolutegravir + Lamivudine vs. Dolutegravir + Tenofovir Disoproxil Fumarate/Emtricitabine: Very-Low-Level HIV-1 Replication through 144 Weeks in the GEMINI-1 and GEMINI-2 Studies.

Mark Underwood, Rimgaile Urbaityte, Ruolan Wang

|Dec 23, 2023
A Comprehensive Literature Review of Treatment-Emergent Integrase Resistance with Dolutegravir-Based Regimens in Real-World Settings.

Cassidy Henegar, Emilio Letang, Ruolan Wang

Pageof 1

Frequent Collaborators

2 joint publications

Richard Grove

1 joint publications

Mark Underwood

1 joint publications

Anna Maria Geretti

1 joint publications

Jade Ghosn